Figure 2.
Exosc3 expression in the hematopoietic system confers erythroid progenitor activity in an erythroid cell–intrinsic manner. (A) Exosc3 ablation did not affect cellular viability, assessed by DAPI staining. (B) GFP+ percentage of live fetal liver cells. Significance by Tukey multiple comparisons test. (C) GFP+ percentage from live R1 cells parent gate. Significance by Tukey multiple comparisons test. (D) Representative flow cytometric plots depicting erythroid maturation based on CD71 and Ter119 expression in Exosc3C/C Cre− and Exosc3C/C Cre+ E14.5 embryos (13 independent experiments: Exosc3C/C Cre− = 21 and Exosc3C/C Cre+ = 17). (E) Quantification of R1 to R4 populations from E14.5 fetal livers. (F) Experimental scheme for assessing CFU activity of Exosc3C/C Cre− and Exosc3C/C Cre+ of sorted GFP+ R1 + R2 from E12.5 or E14.5 fetal livers. Colonies were quantified after 3 days (CFU-E) or 8 days (BFU-E and CFU-GM) in methylcellulose. (G) CFU activity of Exosc3C/C Cre− and Exosc3C/C Cre+ 3000 sorted GFP+ R1 + R2 cells from E12.5 fetal livers (7 independent experiments: Exosc3C/C Cre− = 7 and Exosc3C/C Cre+ = 6). (H) CFU activity of Exosc3C/C Cre− and Exosc3C/C Cre+ with 5000 sorted GFP+ R1 + R2 from E14.5 fetal livers (7 independent experiments: Exosc3C/C Cre− = 9 and Exosc3C/C Cre+ = 6). Quantitative data are presented as box and whisker plots, with bounds from the 25th to 75th percentiles, the median line, and whiskers ranging from minimum to maximum values. ∗P < .05, ∗∗P < .01, and ∗∗∗P < .001, by unpaired t test. APC, allophycocyanin.